Pancreatic Cancer Research

ResearcherJinan UniversityNo recent work listed

Jibing Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8596-2126; OpenAlex author ID A5022681647. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 4 papers · 2018: 2 papers · 2019: none · 2020: 3 papers

Papers 12

  1. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients. Co-author DOI 10.1038/s41392-020-00260-1↗
  2. Irreversible electroporation for liver metastasis from pancreatic cancer: A case report. Co-author DOI 10.12998/wjcc.v8.i2.390↗
  3. Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer. Co-author DOI 10.12998/wjcc.v8.i22.5564↗
  4. Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer. Co-author DOI 10.1007/s12026-017-8959-2↗
  5. Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. Co-author DOI 10.1159/000490874↗
  6. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic c… Co-author DOI 10.1007/s00432-017-2513-4↗
  7. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cance… Co-author DOI 10.1016/j.imlet.2017.03.018↗
  8. Percutaneous Irreversible Electroporation for Ablation of Locally Advanced Pancreatic Cancer: Experience From a Chinese Institution. Co-author DOI 10.1097/mpa.0000000000000703↗
  9. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer. Co-author DOI 10.18632/oncotarget.21974↗
  10. Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block. Co-author DOI 10.1016/j.cryobiol.2012.12.002↗
  11. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. First author DOI 10.1097/mpa.0b013e3182965dde↗
  12. Radical treatment of stage IV pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation. Co-author DOI 10.3748/wjg.v18.i47.7056↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lizhi Niu · 11 shared papers, 2013–2020 · strength 0.91
  2. Mao Lin · 6 shared papers, 2017–2020 · strength 0.50
  3. Kecheng Xu · 7 shared papers, 2013–2018 · strength 0.46
  4. Mohammed Alnaggar · 4 shared papers, 2017–2020 · strength 0.36
  5. Yangyang Ma · 2 shared papers, 2020 · strength 0.28
  6. Xiaoyan Zhang · 1 shared paper, 2020 · strength 0.11
  7. Yong Jiang · 1 shared paper, 2020 · strength 0.11
  8. Yishi Zhang · 1 shared paper, 2017 · strength 0.06
  9. Kecheng Xu · 1 shared paper, 2017 · strength 0.06
  10. Li Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.